Literature DB >> 10832852

MDMA (Ecstasy) neurotoxicity: assessing and communicating the risks.

B P Boot1, I S McGregor, W Hall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10832852     DOI： 10.1016/S0140-6736(00)02276-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance.

Authors:  Maartje M L De Win; Gerry Jager; Hylke K E Vervaeke; Thelma Schilt; Liesbeth Reneman; Jan Booij; Frank C Verhulst; Gerard J Den Heeten; Nick F Ramsey; Dirk J Korf; Wim Van den Brink
Journal:  Int J Methods Psychiatr Res       Date:  2005       Impact factor: 4.035

2.  Reduced N-acetylaspartate levels in the frontal cortex of 3,4-methylenedioxymethamphetamine (Ecstasy) users: preliminary results.

Authors:  Liesbeth Reneman; Charles B L M Majoie; Herman Flick; Gerard J den Heeten
Journal:  AJNR Am J Neuroradiol       Date:  2002-02       Impact factor: 3.825

Review 3.  The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.

Authors:  H Kalant
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

4.  Increased anxiety and "depressive" symptoms months after MDMA ("ecstasy") in rats: drug-induced hyperthermia does not predict long-term outcomes.

Authors:  Iain S McGregor; Clint G Gurtman; Kirsten C Morley; Kelly J Clemens; Arjan Blokland; Kong M Li; Jennifer L Cornish; Glenn E Hunt
Journal:  Psychopharmacology (Berl)       Date:  2003-04-17       Impact factor: 4.530

5.  Differential alteration of the effects of MDMA (ecstasy) on locomotor activity and cocaine conditioned place preference in male adolescent rats by social and environmental enrichment.

Authors:  Amy K Starosciak; Elena Zakharova; Monica Stagg; Jannifer Matos; Sari Izenwasser
Journal:  Psychopharmacology (Berl)       Date:  2012-07-01       Impact factor: 4.530

Review 6.  Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices.

Authors:  Rafael de la Torre; Magí Farré; Mónica Navarro; Roberta Pacifici; Piergiorgio Zuccaro; Simona Pichini
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

7.  Using Confidence Interval-Based Estimation of Relevance to Select Social-Cognitive Determinants for Behavior Change Interventions.

Authors:  Rik Crutzen; Gjalt-Jorn Ygram Peters; Judith Noijen
Journal:  Front Public Health       Date:  2017-07-13

8.  Social Cognition and Interaction in Chronic Users of 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy").

Authors:  Michael D Wunderli; Matthias Vonmoos; Lorena Treichler; Carmen Zeller; Isabel Dziobek; Thomas Kraemer; Markus R Baumgartner; Erich Seifritz; Boris B Quednow
Journal:  Int J Neuropsychopharmacol       Date:  2018-04-01       Impact factor: 5.176
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.